Improved control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain. (Q42608659)
Jump to navigation
Jump to search
scientific article published on January 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Improved control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain. |
scientific article published on January 2003 |
Statements
Improved control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain (English)
Cristina Fernandez-Perez
1 reference
1 January 2003